s6y
Company name or ticker
Search
Amylyx Pharmaceuticals, Inc.
4
MILNE GEORGE M JR: Statement of changes in beneficial ownership of securities
Filed
Wednesday, October 7, 2026
Period
Oct 5, 2026
Accession number
0001193125-26-416950
Documents
4
4
On sec.gov
Filing index
All files
Complete submission text
SGML header